4-(tert-Butyl)picolinic acid hydrochloride

Catalog No.: 
ACURXG524
CAS No.: 
123811-75-6
Molecular Formula: 
C10H14ClNO2
Molecular Weight: 
215.68
4-(tert-Butyl)picolinic acid hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$60.00InquiryInquiry
1g97%$116.00InquiryInquiry
5g97%$375.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(tert-Butyl)picolinic acid hydrochloride
IUPAC Name4-(tert-butyl)picolinic acid hydrochloride
MDL No.MFCD19690370
Molecular FormulaC10H14ClNO2
Molecular Weight215.68
SMILESO=C(O)C1=NC=CC(C(C)(C)C)=C1.[H]Cl
InChI KeyXPWCKHRFHCBIJA-UHFFFAOYSA-N
Synonym4-(tert-Butyl)picolinic acid hydrochloride | 123811-75-6 | 4-tert-butylpyridine-2-carboxylic acid;hydrochloride | 2-Pyridinecarboxylic acid, 4-(1,1-dimethylethyl)-, hydrochloride (1:1) | 4-tert-butylpyridine-2-carboxylic acid hydrochloride | SCHEMBL3190585 | XPWCKHRF
CAS No.123811-75-6
PubChem CID14482381

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACURXG524 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHJEQ856 route compound structure diagram
    ACHJEQ85642205-73-2In Stock
  2. Then
  3. ACURXG524 route product structure diagram
    ACURXG524123811-75-6
Inquiry

2. ACURXG524 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEWYM932 route compound structure diagram
    ACEWYM932177784-98-4In Stock
  2. Then
  3. ACURXG524 route product structure diagram
    ACURXG524123811-75-6
Inquiry

3. ACURXG524 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACURXG524 route product structure diagram
    ACURXG524123811-75-6
Inquiry

Comments (0)